The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.

La présente invention se relie généralement aux compositions pharmaceutiques stables, et aux méthodes de la fabrication et administrer de telles compositions. Dans un aspect, l'invention comporte les compositions pharmaceutiques stabilisées qui incluent pharmaceutiquement les substances actives telles que le sodium du levothyroxine (T4) et le sodium du liothyronine (T3) (drogues d'hormone thyroïde), de préférence sous une forme galénique pleine de dégagement immédiat. En outre fournies sont des méthodes pour faire et usage de tels dégagement immédiat et compositions stabilisées.

 
Web www.patentalert.com

< Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists

< Compounds for diagnosis of tuberculosis and methods for their use

> Eye treatments using synthetic thyroid hormone compositions

> Covalent modification of abnormal prion protein

~ 00068